Cannabis Law Report

JULY 21, 2022

Kabir Nath brings decades of experience in the health care industry to his new role, most recently serving as Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical Co.,

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

NORML

JULY 1, 2019

Previously, Virginia’s five licensed medical cannabis providers, called pharmaceutical processors, would have been limited to dispensing only oils when they open their doors later this year. “Virginia is moving in the right direction to ensure patients and doctors can choose treatments that are right for them.

Law 262

Law Patients Access Oil 262

Cannabis Law Report

APRIL 21, 2022

MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

The Cannigma

MAY 1, 2023

The government has recognized the need to address the issue of drug abuse and addiction in the country, but its approach has been focused primarily on law enforcement rather than prevention and treatment. The future of cannabis regulation in Ghana The future of cannabis laws in Ghana is uncertain.

Law 52

Law Cultivation Treatment Programs 52

Cannabis Law Report

JUNE 2, 2021

and has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.” Pharmaceutical Grade CBD Oil. Epidiolex is a Schedule V controlled substance approved for the treatment of seizures. Idaho Office of Drug Policy: Cannabidiol (CBD): [link].

Law 103

Law Marijuana Oil Pharmaceutical 103

Veriheal

OCTOBER 29, 2020

Is the focus on the negative impact due to the fact that role players want cannabis to remain illicit as to avoid its potential role in replacing pharmaceutical medication? Scenario 2: Pharmaceuticals. However, the focus of funding remains on negative impacts. How could we move the focus towards understanding the benefits?

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

JANUARY 16, 2020

The European Medicinal Cannabis Association (EUMCA), the newly formed Brussels-based industry body which advocates for European evidence-based policy to improve patient access to high-quality cannabis treatment, has announced the appointment of Professor Jones, CBE, FMedSci, as its new Chairman. Professor Jones.

Medicine 59

Medicine Research and Development Pharmaceutical Policy 59

Cannabis Law Report

FEBRUARY 5, 2020

The success of our pharmaceutical arm Eco Equity over the past 18 months shows there is appetite for investment in the industry. We want our investors to feel confident and we want our investors to see returns, as well as achieving our main aim of finding alternative and natural treatments for life-threatening illnesses.”.

Seed-To-Sale 59

Seed-To-Sale Pharmaceutical Medicine Cultivation 59

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. Knowledge, attitudes and policies regarding medical cannabis and cannabis-based drugs are changing. Cannabidiol-based treatment receives marketing approval from EMA.

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

MMJ Recs

JUNE 26, 2020

Dispensing pharmaceuticals. Nursing practice often involves dispensing pharmaceuticals and providing direct patient care services. Employers have different policies when it comes to medical marijuana and nursing practice. Maintaining, repairing, or operating heavy equipment, or manufacturing processes.

Marijuana 69

Marijuana Safety Pharmaceutical Patients 69

The Blunt Truth

APRIL 20, 2021

Although not immediately effective, New Mexico and Virginia employers should immediately assess the implications of the laws on their current policies and drug testing practices. Virginia went further by enacting the first law providing employment protections to individuals using cannabis oil. Virginia’s Cannabis Oil Law.

Recreational 77

Recreational Legalization Oil Extraction 77

SpeedWeed

MARCH 13, 2021

Parkinson’s disease patients typically use pharmaceutical medications to treat their condition with varying degrees of success. However, common treatments do not address the non-motor symptoms and can sometimes cause side effects including dyskinesia, an abnormality or impairment of voluntary movement. . View original article.

Patients 52

Patients Treatment Therapy Sleep 52

United Patients Group

FEBRUARY 7, 2023

Cannabis is an effective treatment for pain and inflammation Cannabis is a natural alternative to pharmaceutical drugs. Cannabinoids like CBD have been found to be effective treatments for inflammation, including stomach ulcers and irritable bowel syndrome (IBS). It’s found in cannabis, as well as oranges and lemons.

Cannabinoids 114

Cannabinoids Chronic Pain Terpenes THC 114

MJ Business Attorneys

JUNE 29, 2018

The FDA’s approval of the drug is just one step toward getting Epidiolex on the market and available to doctors to prescribe as a treatment option. The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

The Cannigma

NOVEMBER 2, 2021

Overall, 65% of the respondents said that they use cannabis in lieu of prescription pharmaceuticals. The survey was compiled by Amanda Reiman , PhD MSW, the California policy manager for the Drug Policy Alliance. In addition, they were also significantly more likely to report more use days per week.

Cannabis 134

Cannabis Policy Pharmaceutical Patients 134

Canna Law Blog

MAY 2, 2020

That article posited that psilocybin would move along two tracks similar to cannabis (medical and pharmaceutical) before approaching the “retail model” initiatives that became standard with adult use cannabis. The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not) ).

Decriminalization 54

Decriminalization Treatment Therapy Pharmaceutical 54

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Canna Law Blog

FEBRUARY 19, 2020

The second track for psilocybin is the pharmaceutical model. On the pharmaceutical side, the FDA’s willingness to grant breakthrough therapy status to psychedelic drugs, as mentioned above, has put psilocybin approvals in an expeditious place. At some point, federal policy finally evolves and change becomes inevitable.

Decriminalization 110

Decriminalization Research and Development Therapy Pharmaceutical 110

Cannabis Law Report

JUNE 7, 2019

The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. Cannabinoids are chemical compounds found in the cannabis plant.

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

The Cannigma

MARCH 25, 2021

Executive Director of the Criminal Justice Policy Foundation told The Cannigma during a Zoom call this week. “A Sterling mentioned fears that officials may have about cannabis making its way out into the general population of the prison, though he added that’s a concern with any pharmaceutical provided by prison health services.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. The panel would center on the evolution of cannabis policy in the U.S.,

Research and Development 52

Research and Development Events Topical Policy 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera is an accomplished cross-functional leader in the healthcare industry, with over 20 years of experience in the development and implementation of complex market access strategies including health policy, pricing and reimbursement, contracts and coding. CAMBRIDGE, Mass.–(BUSINESS Sesen Bio, Inc.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

DECEMBER 9, 2021

Bipartisan support for psychedelic treatment is also developing rapidly, with former Texas Governor Rick Perry (R) supporting legislation allowing for clinical research of psilocybin to help veterans suffering from PTSD. Psychedelics in the Pharmaceutical Space. Priorities of the Psychedelic Industry: Spiritualism or Commerce?

Legalization 52

Legalization Research and Development Pharmaceutical Recreational 52

Weedistry

DECEMBER 29, 2018

Two years ago, the people of Florida overwhelmingly voted to approve Amendment 2, creating a constitutional right for those with medical conditions to seek treatment through medical marijuana. Across the state, there are doctors — like me — who have started up clinics to help determine and facilitate treatment for those who need it most.

Chronic Pain 45

Chronic Pain Pharmaceutical Treatment Patients 45

Cannabis Law Report

JANUARY 16, 2020

Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this. About Devonian. Devonian Health Group Inc.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

Cannabis Law Report

FEBRUARY 22, 2020

The second track for psilocybin is the pharmaceutical model. On the pharmaceutical side, the FDA’s willingness to grant breakthrough therapy status to psychedelic drugs, as mentioned above, has put psilocybin approvals in an expeditious place. At some point, federal policy finally evolves and change becomes inevitable.

Decriminalization 59

Decriminalization Research and Development Therapy Pharmaceutical 59

The Cannigma

OCTOBER 20, 2021

Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. believe that medical cannabis is a legitimate treatment option and that 86% see it as a therapeutic agent for treating cancer and chemotherapy-induced side effects.

Legalization 59

Legalization Decriminalization Patients Medicine 59

Cannabis Law Report

FEBRUARY 20, 2022

However, many countries have adopted decriminalization policies to make it a non-criminal offense. This compound is known to be made from hemp and is widely used in the United States in the production of CBD oil, mainly used as a partial treatment for various ailments. Let’s talk about Cannabis. What Makes CBD Legal? or less.

CBD 52

CBD Legalization Oil Agriculture 52

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

On June 25, 2018, the Food and Drug Administration announced that it approved the drug Epidiolex for the treatment of seizures in connection with epilepsy. Under the CSA, CBD remains a Schedule I substance, which means that it is not considered to have any currently accepted medical use. While … Keep reading.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

Cannabis Law Report

NOVEMBER 8, 2021

As the fund works to bring to market psychedelic treatments that are poised to revolutionize the way we treat mental health and addiction issues, Palo Santo has appointed Charles D. drug policy reform and is a New York Times best-selling author. Nichols, PhD , Dr. Julie Holland , Dr. John F. Dr. Holland has worked for decades on U.S.

Research and Development 52

Research and Development Medicine Treatment Access 52

Cannabis Law Report

JULY 19, 2021

Philip Morris International recently offered £1 billion to buy Vectura Group PLC, the British pharmaceutical company that develops inhaled medical products. The global market for inhalation drug delivery devices is predicted to reach $17.6 billion by 2027. About RYAH Group, Inc. Client Relations. +1 1 917 210 0543.

Therapy 76

Therapy Data Research and Development Events 76

The Cannigma

OCTOBER 20, 2021

In a June, 2020 interview, a Swiss drug policy expert told Marijuana Business Daily that the scientific process behind the pilot program is expected to last five years, and that if everything goes as planned, the matter of full recreational cannabis legalization for adults could be debated by 2030. How do the Swiss generally view marijuana?

Legalization 52

Legalization Decriminalization Patients Medicine 52

Cannabis Law Report

OCTOBER 13, 2021

Drug-assisted psychotherapy combines drug and psychological treatments to leverage the benefits of each for a superior outcome. Clearmind Medicine will host ‘Psychedelics for Alcoholism,’ a free, live virtual event highlighting new potential treatments for alcohol use disorder and binge drinking, on Oct. About Clearmind Medicine Inc.

Medicine 52

Medicine Research and Development Therapy Events 52

Cannabis Law Report

MARCH 6, 2019

Meanwhile, states, farmers and other interested parties are clamoring for guidance on hemp commercialization, driven by the steadily increasing demand for CBD products among consumers who believe the hemp derivative is an effective treatment for a wide range of ailments. Read more about Peter Becker Peter’s Linkedin Profile.

CBD 45

CBD Food Hemp Pharmaceutical 45

United Patients Group

FEBRUARY 2, 2023

The cannabinoids found within cannabis have been shown to help boost our natural defenses against illness by improving our overall health status rather than just treating symptoms like most pharmaceuticals do (i.e., antibiotics).

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

The Cannigma

FEBRUARY 21, 2021

Some of them are the same people who have been steering the cannabis industry since its infancy, others are massive beer and pharmaceutical companies, and some come from more unexpected places. billion by Jazz Pharmaceuticals, reportedly the largest-ever deal in the medical cannabis sector. Darrin Harris Frisby/Drug Policy Alliance).

Research and Development 118

Research and Development Pharmaceutical Recreational Cannabis 118